EMA Paediatric Committee elects Sabine Scherer as its new chair
Submitted by Anonymous (not verified) on 24 July 2025 - 14:51
EMA Paediatric Committee elects Sabine Scherer as its new chair
Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2025 - 14:47
Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 17, Status: Authorised
Safety and residue data requirements for the establishment of maximum residue limits in minor species - Scientific guideline
Submitted by Anonymous (not verified) on 24 July 2025 - 14:30
Safety and residue data requirements for the establishment of maximum residue limits in minor species - Scientific guideline
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2025 - 14:18
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Trulicity
Submitted by Anonymous (not verified) on 24 July 2025 - 14:00
Trulicity
LifeGlobal Media - Procedural steps and scientific information after initial consultation (archive)
Submitted by Anonymous (not verified) on 24 July 2025 - 13:30
LifeGlobal Media - Procedural steps and scientific information after initial consultation (archive)
HMA/EMA multi-stakeholder workshop on artificial intelligence, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:00 (CET) to 21 November 2025, 13:00 (CET)
Submitted by Anonymous (not verified) on 24 July 2025 - 13:00
HMA/EMA multi-stakeholder workshop on artificial intelligence, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 November 2025, 13:00 (CET) to 21 November 2025, 13:00 (CET)
Parallel scientific advice and special development aspects or product types
Submitted by Anonymous (not verified) on 24 July 2025 - 12:57
Parallel scientific advice and special development aspects or product types
EU Repurposing pilot
Submitted by Anonymous (not verified) on 24 July 2025 - 12:55
EU Repurposing pilot
Guideline on the pharmaceutical quality of inhalation and nasal medicinal products - Revision 1
Submitted by Anonymous (not verified) on 24 July 2025 - 12:45
Guideline on the pharmaceutical quality of inhalation and nasal medicinal products - Revision 1